These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9365165)

  • 1. 5-Ethynyluracil (GW776): effects on the formation of the toxic catabolites of 5-fluorouracil, fluoroacetate and fluorohydroxypropionic acid in the isolated perfused rat liver model.
    Arellano M; Malet-Martino M; Martino R; Spector T
    Br J Cancer; 1997; 76(9):1170-80. PubMed ID: 9365165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The anti-cancer drug 5-fluorouracil is metabolized by the isolated perfused rat liver and in rats into highly toxic fluoroacetate.
    Arellano M; Malet-Martino M; Martino R; Gires P
    Br J Cancer; 1998; 77(1):79-86. PubMed ID: 9459149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo effect of 5-ethynyluracil on 5-fluorouracil metabolism determined by 19F nuclear magnetic resonance spectroscopy.
    Adams ER; Leffert JJ; Craig DJ; Spector T; Pizzorno G
    Cancer Res; 1999 Jan; 59(1):122-7. PubMed ID: 9892196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of capecitabine, an oral fluorouracil prodrug: (19)F NMR studies in animal models and human urine.
    Desmoulin F; Gilard V; Malet-Martino M; Martino R
    Drug Metab Dispos; 2002 Nov; 30(11):1221-9. PubMed ID: 12386128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 19F NMR monitoring of in vivo tumor metabolism after biochemical modulation of 5-fluorouracil by the uridine phosphorylase inhibitor 5-benzylacyclouridine.
    Holland SK; Bergman AM; Zhao Y; Adams ER; Pizzorno G
    Magn Reson Med; 1997 Dec; 38(6):907-16. PubMed ID: 9402191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blocking catabolism with eniluracil enhances PET studies of 5-[18F]fluorouracil pharmacokinetics.
    Bading JR; Alauddin MM; Fissekis JD; Shahinian AH; Joung J; Spector T; Conti PS
    J Nucl Med; 2000 Oct; 41(10):1714-24. PubMed ID: 11038003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolites of 5-fluorouracil in plasma and urine, as monitored by 19F nuclear magnetic resonance spectroscopy, for patients receiving chemotherapy with or without methotrexate pretreatment.
    Hull WE; Port RE; Herrmann R; Britsch B; Kunz W
    Cancer Res; 1988 Mar; 48(6):1680-8. PubMed ID: 3125967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formation of conjugates of 2-fluoro-beta-alanine and bile acids during the metabolism of 5-fluorouracil and 5-fluoro-2-deoxyuridine in the isolated perfused rat liver.
    Sweeny DJ; Barnes S; Diasio RB
    Cancer Res; 1988 Apr; 48(8):2010-4. PubMed ID: 2964897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical development of eniluracil: enhancing the therapeutic index and dosing convenience of 5-fluorouracil.
    Paff MT; Baccanari DP; Davis ST; Cao S; Tansik RL; Rustum YM; Spector T
    Invest New Drugs; 2000 Nov; 18(4):365-71. PubMed ID: 11081572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of 5-diazouracil on the catabolism of circulating pyrimidines in rat liver and kidneys.
    Holstege A; Pausch J; Gerok W
    Cancer Res; 1986 Nov; 46(11):5576-81. PubMed ID: 3756903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluoropyrimidine chemotherapy in a rat model: comparison of fluorouracil metabolite profiles determined by high-field 19F-NMR spectroscopy of tissues ex vivo with therapy response and toxicity for locoregional vs systemic infusion protocols.
    Lutz NW; Naser-Hijazi B; Koroma S; Berger MR; Hull WE
    NMR Biomed; 2004 May; 17(3):101-31. PubMed ID: 15137037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-Ethynyluracil (776C85): effects on the antitumor activity and pharmacokinetics of tegafur, a prodrug of 5-fluorouracil.
    Cao S; Baccanari DP; Joyner SS; Davis ST; Rustum YM; Spector T
    Cancer Res; 1995 Dec; 55(24):6227-30. PubMed ID: 8521418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [In-vivo 19F-MRS study of 5-fluorouracil (5-FU) metabolism on tumors].
    Harada M; Nishitani H; Shirahama T; Koga K; Miura I
    Gan To Kagaku Ryoho; 1991 Jan; 18(1):75-80. PubMed ID: 1899014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism of a novel nucleoside analogue, OGT 719, in the isolated perfused rat liver model, in rats, in tumour models and in patients.
    Desmoulin F; Gilard V; Malet-Martino M; Martino R; Molina C; Smith P
    Xenobiotica; 2003 Mar; 33(3):289-303. PubMed ID: 12637246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-Ethynyluracil (776C85): protection from 5-fluorouracil-induced neurotoxicity in dogs.
    Davis ST; Joyner SS; Baccanari DP; Spector T
    Biochem Pharmacol; 1994 Jul; 48(2):233-6. PubMed ID: 8053919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-time follow-up of 5-fluorouracil metabolism in the liver of tumor patients by means of F-19 MR spectroscopy.
    Semmler W; Bachert-Baumann P; Gückel F; Ermark F; Schlag P; Lorenz WJ; van Kaick G
    Radiology; 1990 Jan; 174(1):141-5. PubMed ID: 2104675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extraction of 5-fluorouracil by tumor and liver: a noninvasive positron emission tomography study of patients with gastrointestinal cancer.
    Aboagye EO; Saleem A; Cunningham VJ; Osman S; Price PM
    Cancer Res; 2001 Jul; 61(13):4937-41. PubMed ID: 11431319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurotoxic effects of alpha-fluoro-beta-alanine (FBAL) and fluoroacetic acid (FA) on dogs.
    Yamashita K; Yada H; Ariyoshi T
    J Toxicol Sci; 2004 May; 29(2):155-66. PubMed ID: 15206584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of 5-fluorouracil catabolism in isolated rat hepatocytes with enhancement of 5-fluorouracil glucuronide formation.
    Sommadossi JP; Gewirtz DA; Cross DS; Goldman ID; Cano JP; Diasio RB
    Cancer Res; 1985 Jan; 45(1):116-21. PubMed ID: 3965128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical modulation of the catabolism and tissue uptake of the anticancer drug 5-fluorouracil by 5-bromovinyluracil: assessment with metabolic (19)F MR imaging.
    Brix G; Bellemann ME; Haberkorn U
    Magn Reson Med; 1999 Nov; 42(5):936-43. PubMed ID: 10542353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.